Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Divestments (2019 - 2025)

Fortress Biotech (FBIO) has 2 years of Divestments data on record, last reported at $2.9 million in Q3 2025.

  • For Q3 2025, Divestments changed N/A year-over-year to $2.9 million; the TTM value through Sep 2025 reached $2.9 million, changed N/A, while the annual FY2021 figure was $56.9 million, N/A changed from the prior year.
  • Divestments reached $2.9 million in Q3 2025 per FBIO's latest filing, up from -$13.1 million in the prior quarter.
  • Across five years, Divestments topped out at $2.9 million in Q3 2025 and bottomed at $2.9 million in Q3 2025.